| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC2225 | Gc-204 | Selective inhibitor of carbonic anhydrase IX (CAIX) |
|
| DCC2226 | Gc-205 | Selective inhibitor of carbonic anhydrase IX (CAIX) |
|
| DCC2227 | Gca-186 | Highly potent non-nucleoside inhibitor of HIV-1 reverse transcriptase |
|
| DCC2228 | Gcc5694a | Novel Potent and Selective Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitor for the Treatment of Type 2 Diabetes |
|
| DCC2229 | Gcs Inhibitor Bz1 | Novel glucosylceramide synthase (GCS) inhibitor, rescuing lysosomal deficits, α-synuclein pathology and neuron toxicity |
|
| DCC2230 | Gdc0575 | Novel highly-selective oral checkpoint kinase 1 (Chk1) inhibitor |
|
| DCC2231 | Gdc-0575 Dihydrochloride | Novel potent, selective and orally bioavailable Chk1 inhibitor |
|
| DCC2232 | Gdc-0834 | Novel Bruton's tyrosine kinase (BTK) inhibitor |
|
| DCC2233 | Gdc-0917 | Novel SMAC mimetic and IAP antagonist |
|
| DCC2235 | Gdk-100017 | Inhibitor of the Wnt/beta-catenin signaling pathway, suppressing cell proliferation and enhancing radiosensitivity in A549/Wnt2 cells. |
|
| DCC2236 | Gebr-7b | Novel Phosphodiesterase 4D (PDE4D) Inhibitor |
|
| DCC2237 | Geiparvarin | MAO inhibitor |
|
| DCC2238 | Genaconazole | Novel antifungal agent |
|
| DCC2239 | Geneseroline | Metabolite of ganstigmine, a novel acetylcholinesterase inhibitor |
|
| DCC2240 | Geopyxin C | Natural covalent Cys151-dependent NRF2 activator |
|
| DCC2241 | Geopyxin F | Natural non-covalent NRF2 activator, activating NRF2 in A KEAP1-dependent but Cys151-independent manner, conferring greater protection than a Cys151-dependent analog, geopyxin C |
|
| DCC2242 | GFB-12811 Featured | GFB-12811 is a high selective and orally active CDK5 inhibitor with an IC50 of 2.3 nM. GFB-12811 is highly selective over the other tested kinases (CDK1/2/6/7/9). |
.gif)
|
| DCC2243 | G-glu-glu | Endogenous dipeptide, activating N-methyl-D-aspartate receptors |
|
| DCC2244 | Ghsr Inverse Agonist 29 | Novel nonpeptidic inverse agonist of the Ghrelin Receptor (GHSR) |
|
| DCC2245 | Gi-129471 | Metalloproteinase inhibitor, specifically blocking TNF-alpha secretion both in vitro and in vivo |
|
| DCC2246 | Gi261520a | Potent EGFR/erbB2 dual inhibitor |
|
| DCC2247 | Gic-1001 | Novel oral anti-nociceptive agent, showing peripheral opioid agonistic activity and hydrogen sulphide-releasing capacity |
|
| DCC2248 | Gidazepam | Potent mitochondrial benzodiazepine receptors (MBRs) ligand; Prodrug for its active metabolite bromo-nordazepam |
|
| DCC2249 | Gif-0854-r | Novel suppressor of endoplasmic reticulum (ER) stress and oxidative stress, preventing protein aggregate accumulation in vitro and in cultured hippocampal HT22 neuronal cells, as well as glutamate-induced oxytosis and erastin-induced ferroptosis |
|
| DCC2250 | Gif-0856-r | Novel suppressor of endoplasmic reticulum (ER) stress and oxidative stress, preventing protein aggregate accumulation in vitro and in cultured hippocampal HT22 neuronal cells, as well as glutamate-induced oxytosis and erastin-induced ferroptosis |
|
| DCC2251 | Gilteritinib Fumarate Featured | Gilteritinib (ASP2215) hemifumarate is a potent and ATP-competitive FLT3/AXL inhibitor with IC50 of 0.29 nM/0.73 nM, respectively. |
|
| DCC2252 | Ginkgonitroside | Natural suppressor of mesenchymal stem cell (MSC) differentiation |
|
| DCC2253 | Ginnalin A | Natural Activator of the Nrf2-Regulated Antioxidant Defense System in SH-SY5Y Cells, Binding to the Subpockets of Keap1 Kelch Domain |
|
| DCC2254 | Gk-136901 | First-in-Class, Potent, and Orally Bioavailable NADPH Oxidase Isoform 4 (Nox4) Inhibitor |
|
| DCC2255 | Gk-667 | Novel water solubile prodrug of ICRF-193, penetrating into NVCMs, reaching intracellular concentrations sufficient to induce cytoprotective effects against ANT toxicity |
|
